Nalaganje...

Evaluation and correlation of risk recurrence in early breast cancer assessed by Oncotype DX(®), clinicopathological markers and tumor cell dissemination in the blood and bone marrow

The Oncotype DX(®) assay is a validated genomic test that predicts the likelihood of breast cancer recurrence, patient survival within ten years of diagnosis and the benefit of chemotherapy in early-stage, node-negative, estrogen receptor-positive breast cancer. Further markers of recurrence include...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: AKTAS, BAHRIYE, BANKFALVI, AGNES, HEUBNER, MARTIN, KIMMIG, RAINER, KASIMIR-BAUER, SABINE
Format: Artigo
Jezik:Inglês
Izdano: D.A. Spandidos 2013
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3915634/
https://ncbi.nlm.nih.gov/pubmed/24649291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2013.174
Oznake: Označite
Brez oznak, prvi označite!